Altered Synthesis of Interferon-γ and Expression of Interferon-γ Receptor by Peripheral Blood Mononuclear Cells from Patients with IgA Nephropathy and Non-IgA Proliferative Glomerulonephritis

Journal of Clinical Immunology

Volumn 16, Issue 1, 1996, Pages 71-79

  Yano, Naohiro ^a   Endoh, Masayuki ^a   Naka, Raita ^a   Takemura, Fumio ^a   Nomoto, Yasuo ^a   Sakai, Hideto ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

IgA nephropathy; Interferon ; Macrophages; Natural killer cells

Indexed keywords

GAMMA INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INTERFERON PRODUCTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS;

ANTIGENS, CD; BASE SEQUENCE; CELL COUNT; CELL-FREE SYSTEM; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MONOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, INTERFERON; RNA, MESSENGER;

EID: 0029670947     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01540975     Document Type: Article

References (33)

1. Cameron JS: The long-term outcome of glomerular diseases. In Diseases of the Kidney, RW Schrier, CW Gottschalk (eds). Boston, Little, Brown, 1993, pp 1895-1958
2. Lovett DH, Szamel M, Ryan JL, Sterzel RB, Gemsa D, Resch K: Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol 136:3700-3705, 1986
3. Lai KN, Leung JCK, Li PKT, Lui SF: Cytokine production by peripheral blood mononuclcar cells in IgA nephropathy. Clin Exp Immunol 85:240-245, 1991
4. Yano N, Endoh M, Miyazaki M, Yamauchi F, Nomoto Y, Sakai H: Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy. Clin Exp Immunol 88:295-300, 1992
5. Fukatsu A, Matsuo S, Tamai H, Sakamoto N, Matsuda T, Hirano T: Distribution of interleukin-6 in normal and diseased human kidney. Lab Invest 65:61-66, 1991
6. Wada T, Yokoyama H, Tomosugi N, Hisada Y, Ohta S, Naito T, Kobayashi K, Mukaida N, Matsushima K: Detection of urinary interleukin-8 in glomerular diseases. Kidney Int 46:455-460, 1994
7. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
8. Gesualdo L, Pizani M, Floriano JJ, Hassan MO, Nagy NU, Schena FP, Emancipator SN, Abboud HE: Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167, 1991
9. Gomez-Chiarri M, Ortiz A, Lerma JL, Lopez-Armada MJ, Mampaso F, Gonzalez E, Egido J: Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70:449-459, 1994
10. Samuel CE: Antiviral actions of interferon; Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11, 1991
11. Dunn PL, North RJ: Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect Immun 59:2892-2900, 1991
12. Basham TY, Merigan TC: Recombinant interferon-γ increases HLA-DR synthesis and expression. J Immunol 130:1492-1494, 1983
13. Sheehan KCF, Calderson J, Schreiber RD: Generation and characterization of monoclonal antibodies specific for the human IFN-γ receptor. J Immunol 140:4231-4237, 1988
14. Jung V, Jones C, Kumar CS, Stefanos S, O'Connell S, Pestka S: Expression and reconstitution of a biologically active human interteron-γ receptor in hamster cells. J Biol Chem 265:1827-1830, 1990
15. Yokoyama H, Takeda M, Wada T, Ogi M, Tomosugi N, Takabatake T, Abe T, Yoshimura M, Kida H, Kobayashi K: Intraglomerular expression of MHC class II and Ki-67 antigens and serum γ-interferon levels in IgA nephropathy. Nephron 62:169-175, 1992
16. Montinaro V, Hevey K, Aventaggiato L, Fadden K, Esparza A, Chen A, Finbloom DS, Rifai A: Extrarenal cytokines modulate the glomerular response to IgA immune complexes. Kidney Int 42: 341-353, 1992
17. Mene P, Pugliese F, D'Agostino A, Cinotti GA: Thromboxane A2, prostaglandins, and mesangial cell proliferation. Kidney Int 41: 554-556, 1992
18. Ohta K, Hirata Y, Shichiri M, Kanno K, Emori T, Tomita K, Marumo F: Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 39:307-311, 1991
19. Lai KN, Leung JCK, Lai FM, Tam JS: T-lymphocyte activation in IgA nephropathy. Serum-soluble Interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes. J Clin Immunol 9:485-493, 1989
20. De Caestecker MP, Bottomley M, Telfer BA, Hutchinson IV, Vose BM, Ballardie FW: Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney Int 44:1298-1308, 1993
21. Basham TY, Nickoloff BJ, Merigan TC, Morhenn VB: Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocyles. J Invest Dermatol 83:88-90, 1983
22. Schreiber RD, Pace JL, Russell SW, Altman A, Katz DH: Macrophage-activating factor produced by a T cell hybridoma. Physiochemical and biosynthetic resemblance to g-interferon. J Immunol 131:826-832, 1983
23. Arima S, Nakayama M, Naitoh M, Sato T, Takahashi K: Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 39:684-692, 1991
24. Stachura I, Si L, Madan E, Whiteside T: Mononuclear cell subsets in human renal disease enumeration in tissue sections with monoclonal antibodies. Clin Immunol Immunopathol 30:362-373, 1984
25. Yano N, Endoh M, Kashem A, Miyazaki M, Nomoto Y, Sakai H: Interstitial naive and memory T cells in chronic mesangial proliferative glomerulonephritis. Nephron 64:159-160, 1993
26. Maxwell BL, Talpaz M, Gutterman JU: Down-regulation of peripheral blood cell interferon receptors in chronic myclogenous leukemia patients undergoing human interferon (HulFNα) therapy. Int J Cancer 36:23-28, 1985
27. Langer JA, Pestka S: Interferon receptors. Immunol Today 9:393-400, 1988
28. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451, 1991
29. Malefyt RW, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Jonson K, Kastelein R, Yssel H, de Vries JF: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924, 1991
30. Ozmen L, Romen D, Fountoulakis M, Schmid G, Ryffel B, Garotta G: Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur J Immunol 25:6-12, 1995
31. Bancroft GJ, Schreiber RD, Bosma GC, Bosma MJ, Unanue ER: A T cell-independent mechanism of macrophage activation by interferon-γ. J Immunol 139:1104-1107, 1987
32. Wolf S, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perussia B: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146:3074-3081, 1991
33. Chan SH, Kobayashi M, Santoli D, Perussia B, Trinchieri G: Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of Transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol 148:92-98, 1992